Interim data success for Salubris Biotherapeutics’ heart failure candidate
US company Salubris Biotherapeutics (SalubrisBio) has seen its heart failure therapy, JK07, achieve some success in interim results taken from…
News
Sonnet BioTherapeutics to expand trial of SON-1010 with trabectedin for solid tumours
Exact Sciences post positive results from MRD trial
Advarra introduces Study Collaboration to help improve trial partnership
FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drug
FDA lifts clinical hold on Amylyx’s Phase I ALS trial
Pulse Biosciences touts positive results from PFA early feasibility study
Ascletis Pharma’s ASC30 oral tablet shows promise in obesity trial
